Deng, Xiaoming <br/><br/>
Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Dec 2009 
 - 1071-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.109.158022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiostatins--antagonists & inhibitors<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Blotting, Western<br/>Colitis, Ulcerative--drug therapy<br/>Colon--blood supply<br/>Electrophoresis, Polyacrylamide Gel<br/>Endostatins--antagonists & inhibitors<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Mesalamine--administration & dosage<br/>Neovascularization, Physiologic--drug effects<br/>Rats<br/>Rats, Sprague-Dawley